SHRSP.WKY-(Klk1-D1Rat116)/Izm |
serum triglyceride level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood triglyceride amount |
male |
91 days
| 5 |
42.48 |
mg/dl |
7.96 |
17.81 |
serum triglyceride analysis |
|
0 |
|
0 |
|
|
64857 |
115 |
WKY/Izm |
serum triglyceride level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood triglyceride amount |
male |
91 days
| 5 |
24.78 |
mg/dl |
2.65 |
5.94 |
serum triglyceride analysis |
|
0 |
|
0 |
|
|
64858 |
115 |
F344/NSlc |
serum triglyceride level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood triglyceride amount |
male |
168 days-175 days |
7 |
130.17 |
mg/dl |
15.88 |
42.01 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
TG-E test kits, Wako Chem. Ltd. Osaka, Japan |
97750 |
1918 |
F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj |
serum triglyceride level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood triglyceride amount |
male |
168 days-175 days |
10 |
1240.6 |
mg/dl |
209.56 |
662.69 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
TG-E test kits, Wako Chem. Ltd. Osaka, Japan |
97753 |
1918 |
SS.ZUC-Leprfa+/+/Slc |
serum triglyceride level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood triglyceride amount |
male |
91 days
| 8 |
54.5 |
mg/dl |
9.5 |
26.87 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
101849 |
2641 |
SHR/FubRkb |
serum triglyceride level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood triglyceride amount |
not specified |
168 days
| 10 |
61.95 |
mg/dl |
3.54 |
11.19 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
serum triglyceride analysis |
65384 |
117 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum triglyceride level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood triglyceride amount |
male |
168 days-175 days |
7 |
80.54 |
mg/dl |
8.04 |
21.27 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
TG-E test kits, Wako Chem. Ltd. Osaka, Japan |
97751 |
1918 |
FHH-Nr4a1m1Mcwi |
serum triglyceride level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood triglyceride amount |
male |
56 days
| 6 |
192.0 |
mg/dl |
43.3 |
106.06 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
99512 |
2318 |
WKY/Izm |
serum triglyceride level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood triglyceride amount |
male |
98 days
| 10 |
11.0 |
mg/dl |
1.08 |
3.4 |
serum triglyceride analysis |
|
|
|
0 |
|
|
12499 |
263 |
BN/Seac |
serum triglyceride level |
controlled cholesterol content diet (1 %) (for 14 days) and controlled olive oil content diet (10 %) (for 14 days) |
Asahina M, et al., J Lipid Res 2005 Aug 1 |
blood triglyceride amount |
male |
42 days
| 11 |
79.0 |
mg/dl |
13.3 |
44.11 |
serum triglyceride analysis |
|
|
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
13146 |
71 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum triglyceride level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood triglyceride amount |
male |
218 days
| 11 |
113.5 |
mg/dl |
4.81 |
15.95 |
serum triglyceride analysis |
|
0 |
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
13194 |
311 |
FHH/EurMcwi |
serum triglyceride level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood triglyceride amount |
male |
56 days
| 6 |
32.0 |
mg/dl |
1.4 |
3.43 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
99507 |
2318 |
FHH-Nr4a1m1Mcwi |
serum triglyceride level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood triglyceride amount |
male |
56 days
| 6 |
30.0 |
mg/dl |
3.0 |
7.35 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
99508 |
2318 |
FHH-Nr4a1m1Mcwi |
serum triglyceride level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood triglyceride amount |
male |
56 days
| 6 |
82.0 |
mg/dl |
12.6 |
30.86 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
99510 |
2318 |
Jcl:WI |
serum triglyceride level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood triglyceride amount |
male |
52 days
| 6 |
75.06 |
mg/dl |
6.98 |
17.1 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
103958 |
2884 |
WKY/Izm |
serum triglyceride level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood triglyceride amount |
male |
113 days
| 10 |
15.0 |
mg/dl |
1.8 |
5.7 |
serum triglyceride analysis |
|
|
|
0 |
|
|
12508 |
263 |
ExHC/Seac |
serum triglyceride level |
controlled cholesterol content diet (1 %) (for 14 days) and controlled olive oil content diet (10 %) (for 14 days) |
Asahina M, et al., J Lipid Res 2005 Aug 1 |
blood triglyceride amount |
male |
42 days
| 7 |
216.0 |
mg/dl |
15.5 |
41.01 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
13143 |
71 |
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj |
serum triglyceride level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood triglyceride amount |
male |
218 days
| 7 |
89.9 |
mg/dl |
6.73 |
17.81 |
serum triglyceride analysis |
|
0 |
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
13193 |
311 |
F344/NSlc |
serum triglyceride level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood triglyceride amount |
male |
218 days
| 7 |
108.4 |
mg/dl |
14.5 |
38.36 |
serum triglyceride analysis |
|
0 |
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
13192 |
311 |
MWF/FubRkb |
serum triglyceride level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood triglyceride amount |
not specified |
168 days
| 18 |
95.58 |
mg/dl |
11.5 |
48.81 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
serum triglyceride analysis |
65386 |
117 |
SHRSP.WKY-(Klk1-D1Rat116)/Izm |
serum triglyceride level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood triglyceride amount |
female |
91 days
| 5 |
77.88 |
mg/dl |
11.5 |
25.72 |
serum triglyceride analysis |
|
0 |
|
0 |
|
|
64860 |
115 |
WKY |
serum triglyceride level |
controlled enalapril content drinking water (50 mg/l) (for 26 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood triglyceride amount |
male |
0 days
| 10 |
240.0 |
mg/dl |
19.0 |
60.08 |
serum triglyceride analysis |
|
0.0 |
PA IV 50mg/kg |
19 |
days |
|
100411 |
2479 |
WKY |
serum triglyceride level |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood triglyceride amount |
male |
0 days
| 11 |
55.0 |
mg/dl |
6.0 |
19.9 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
100412 |
2479 |
GK/Jcl |
serum triglyceride level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood triglyceride amount |
male |
52 days
| 6 |
114.12 |
mg/dl |
14.21 |
34.81 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
103959 |
2884 |
GK/Jcl |
serum triglyceride level |
controlled hesperidin content diet (1 %) (for 28 days) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood triglyceride amount |
male |
52 days
| 6 |
56.48 |
mg/dl |
5.56 |
13.62 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
103960 |
2884 |
SS.ZUC-Leprfa+/+/Slc |
serum triglyceride level |
fasting (for 16 hours) |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
blood triglyceride amount |
male |
126 days
| 6 |
102.25 |
mg/dl |
25.98 |
63.64 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
101917 |
2642 |
SS.ZUC-Leprfa-/-/Slc |
serum triglyceride level |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood triglyceride amount |
male |
91 days
| 12 |
1251.33 |
mg/dl |
276.6 |
958.17 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
101852 |
2641 |
SS.ZUC-Leprfa-/-/Slc |
serum triglyceride level |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood triglyceride amount |
male |
91 days
| 7 |
980.67 |
mg/dl |
302.75 |
801.0 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
101952 |
2644 |
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj |
serum triglyceride level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood triglyceride amount |
male |
218 days
| 11 |
111.7 |
mg/dl |
8.83 |
29.29 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
13195 |
311 |
SS/JrTol |
serum triglyceride level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood triglyceride amount |
male |
140 days
| 6 |
106.1 |
mg/dl |
8.5 |
20.82 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
67984 |
834 |
SHRSP/Izm |
serum triglyceride level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood triglyceride amount |
male |
91 days
| 5 |
57.52 |
mg/dl |
10.62 |
23.75 |
serum triglyceride analysis |
|
0 |
|
0 |
|
|
64856 |
115 |
SHRSP/Izm |
serum triglyceride level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood triglyceride amount |
female |
91 days
| 5 |
50.44 |
mg/dl |
11.5 |
25.72 |
serum triglyceride analysis |
|
0 |
|
0 |
|
|
64859 |
115 |
ExHC/Seac |
serum triglyceride level |
control condition |
Asahina M, et al., J Lipid Res 2005 Aug 1 |
blood triglyceride amount |
male |
28 days
| 7 |
98.0 |
mg/dl |
7.3 |
19.31 |
serum triglyceride analysis |
|
|
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
11314 |
71 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
serum triglyceride level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood triglyceride amount |
male |
185 days
| 10 |
191.15 |
mg/dl |
12.39 |
39.18 |
serum triglyceride analysis |
tail vein |
|
|
0 |
|
Vitros TRIG slides (Johnson & Johnson, Rochester, NY) |
11474 |
85 |
SHR/Izm |
serum triglyceride level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood triglyceride amount |
male |
98 days
| 10 |
10.5 |
mg/dl |
0.66 |
2.1 |
serum triglyceride analysis |
|
|
|
0 |
|
|
12448 |
263 |
SHR/Izm |
serum triglyceride level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood triglyceride amount |
male |
113 days
| 10 |
23.8 |
mg/dl |
3.83 |
12.1 |
serum triglyceride analysis |
|
|
|
0 |
|
|
12478 |
263 |
SHR/NHsdMco |
serum triglyceride level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood triglyceride amount |
male |
140 days
| 6 |
63.0 |
mg/dl |
7.5 |
18.37 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
67985 |
834 |
F344.ZUC-Leprfa/Tj |
serum triglyceride level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood triglyceride amount |
male |
168 days-175 days |
10 |
2342.86 |
mg/dl |
269.19 |
851.25 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
TG-E test kits, Wako Chem. Ltd. Osaka, Japan |
97752 |
1918 |
WKY |
serum triglyceride level |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood triglyceride amount |
male |
0 days
| 11 |
231.0 |
mg/dl |
25.0 |
82.92 |
serum triglyceride analysis |
|
0.0 |
PA IV 50mg/kg |
19 |
days |
|
100410 |
2479 |
WKY |
serum triglyceride level |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood triglyceride amount |
male |
0 days
| 12 |
73.0 |
mg/dl |
5.0 |
17.32 |
serum triglyceride analysis |
|
0.0 |
PA IV 50mg/kg |
0 |
|
|
100413 |
2479 |
FHH/EurMcwi |
serum triglyceride level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood triglyceride amount |
male |
112 days
| 6 |
50.0 |
mg/dl |
4.4 |
10.78 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
99511 |
2318 |
F344.ZUC-Leprfa/Tj |
serum triglyceride level |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
blood triglyceride amount |
male |
175 days
| 7 |
2420.6 |
mg/dl |
316.29 |
836.82 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
TG-E test kit (Wako Chem. LTD) |
98078 |
1978 |
GK/Jcl |
serum triglyceride level |
controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood triglyceride amount |
male |
52 days
| 6 |
33.78 |
mg/dl |
2.83 |
6.93 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
103961 |
2884 |
SS.ZUC-Leprfa-/-/Slc |
serum triglyceride level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood triglyceride amount |
male |
91 days
| 7 |
1885.5 |
mg/dl |
325.31 |
860.69 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
101851 |
2641 |
FHH/EurMcwi |
serum triglyceride level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood triglyceride amount |
male |
112 days
| 6 |
37.0 |
mg/dl |
5.3 |
12.98 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
99509 |
2318 |
F344/NSlc |
serum triglyceride level |
control condition |
Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8. |
blood triglyceride amount |
male |
217 days
| 9 |
122.4 |
mg/dl |
25.3 |
75.9 |
serum triglyceride analysis |
|
0 |
|
0 |
|
|
66182 |
716 |
F344.OLETF-(D8Rat58-D8Mgh17)/Tj |
serum triglyceride level |
control condition |
Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8. |
blood triglyceride amount |
male |
217 days
| 20 |
167.8 |
mg/dl |
15.3 |
68.42 |
serum triglyceride analysis |
|
0 |
|
0 |
|
|
66183 |
716 |
F344/DuCrlCrlj |
serum triglyceride level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood triglyceride amount |
male |
185 days
| 9 |
203.54 |
mg/dl |
7.96 |
23.89 |
serum triglyceride analysis |
tail vein |
|
|
0 |
|
Vitros TRIG slides (Johnson & Johnson, Rochester, NY) |
11476 |
85 |
OLETF |
serum triglyceride level |
fasting (for 18 hours) |
Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44. |
blood triglyceride amount |
male |
246 days
| 23 |
218.77 |
mg/dl |
13.47 |
64.62 |
serum triglyceride analysis |
carotid artery |
|
|
0 |
|
Triglyceride E-test Wako, Wako Pure Chemical Industries, Ltd, Osaka, Japan |
12359 |
248 |
F344/NRrrc |
serum triglyceride level |
fasting (for 18 hours) |
Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44. |
blood triglyceride amount |
male |
246 days
| 21 |
131.8 |
mg/dl |
4.52 |
20.72 |
serum triglyceride analysis |
carotid artery |
|
|
0 |
|
Triglyceride E-test Wako, Wako Pure Chemical Industries, Ltd, Osaka, Japan |
12376 |
248 |
BN/Seac |
serum triglyceride level |
control condition |
Asahina M, et al., J Lipid Res 2005 Aug 1 |
blood triglyceride amount |
male |
28 days
| 11 |
108.0 |
mg/dl |
5.9 |
19.57 |
serum triglyceride analysis |
|
|
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
13139 |
71 |
MWF-Chr 6SHR/Rkb |
serum triglyceride level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood triglyceride amount |
not specified |
168 days
| 19 |
108.85 |
mg/dl |
0.88 |
3.86 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
serum triglyceride analysis |
65385 |
117 |
WKY/Izm |
serum triglyceride level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood triglyceride amount |
female |
91 days
| 5 |
40.71 |
mg/dl |
7.96 |
17.81 |
serum triglyceride analysis |
|
0 |
|
0 |
|
|
64861 |
115 |
WKY |
serum triglyceride level |
controlled enalapril content drinking water (50 mg/l) (between 63 and 77 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood triglyceride amount |
male |
0 days
| 12 |
72.0 |
mg/dl |
9.0 |
31.18 |
serum triglyceride analysis |
|
0.0 |
PA IV 50mg/kg |
0 |
|
|
100414 |
2479 |
WKY |
serum triglyceride level |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood triglyceride amount |
male |
0 days
| 10 |
61.0 |
mg/dl |
5.0 |
15.81 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
100409 |
2479 |
F344.ZUC-(Leprfa),OLETF-(D5Rat166-D5Rat90)/Tj |
serum triglyceride level |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
blood triglyceride amount |
male |
175 days
| 5 |
1851.46 |
mg/dl |
150.35 |
336.19 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
TG-E test kit (Wako Chem. LTD) |
98079 |
1978 |
SS.ZUC-Leprfa-/-/Slc |
serum triglyceride level |
fasting (for 16 hours) |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
blood triglyceride amount |
male |
126 days
| 7 |
1559.93 |
mg/dl |
353.89 |
936.3 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
101918 |
2642 |
SS.ZUC-Leprfa+/+/Slc |
serum triglyceride level |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood triglyceride amount |
male |
91 days
| 10 |
87.0 |
mg/dl |
4.08 |
12.9 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
101850 |
2641 |
SS.ZUC-Leprfa-/-/Slc |
serum triglyceride level |
vehicle control condition (0.5 %) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood triglyceride amount |
male |
91 days
| 6 |
2196.13 |
mg/dl |
204.52 |
500.97 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
101950 |
2644 |
SS.ZUC-Leprfa-/-/Slc |
serum triglyceride level |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood triglyceride amount |
male |
91 days
| 7 |
1190.0 |
mg/dl |
324.22 |
857.81 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
101951 |
2644 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
serum triglyceride level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood triglyceride amount |
male |
185 days
| 10 |
268.14 |
mg/dl |
14.16 |
44.78 |
serum triglyceride analysis |
tail vein |
|
|
0 |
|
Vitros TRIG slides (Johnson & Johnson, Rochester, NY) |
11478 |
85 |
SS.SHR-(D2Rat61-D2Mco18)/Mco |
serum triglyceride level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood triglyceride amount |
male |
140 days
| 6 |
90.9 |
mg/dl |
7.5 |
18.37 |
serum triglyceride analysis |
|
0.0 |
|
0 |
|
|
67986 |
834 |